Dietary antioxidant vitamins and minerals and breast cancer risk: prospective results from the SUN cohort
The following AC grouped by chain length were measured: the short chain (SC)-AC: AC2, propionylcarnitine (AC3), iso-/L-valerylcarnitine (AC5)
The decision should be individualized, considering severity of weight concern, presence of metabolic complications, patient preference, cost and access, other treatment options
Clinical trials show semaglutide's weight loss effect averages 15-18% body weight reduction over 68 weeks, independent of when injections occur relative to meals
Sermorelin typically causes mild injection-site reactions and occasional flushing, while semaglutide commonly produces nausea, constipation, or appetite changes that usually resolve within 2 to 4 weeks